logo
Plus   Neg
Share
Email

Bayer Reaches $2 Bln Agreement To Settle Future Roundup Lawsuits

Bayer (BAYZF.PK,BAYRY.PK,BYR.L) has reached up to $2 billion agreement with plaintiffs' attorneys to settle future lawsuits over claims that its Roundup weedkiller causes cancer.

The settlement will provide future plaintiffs, who contract non-Hodgkin lymphoma after using Roundup, up to $200,000 in compensation.

Bayer inherited thousands of lawsuits against Roundup inventor Monsanto Co. when it acquired the U.S. agriculture giant for $63 billion in 2018.

Bayer said plaintiffs' class counsel are filing Wednesday a motion for preliminary approval of the class agreement with Judge Vince Chhabria of the U.S. District Court for the Northern District of California, who presides over the Monsanto Roundup multi-district litigation.

Bayer noted that elements of the revised plan include the establishment of a fund to compensate qualified claimants during an initial four year program, an advisory science panel whose findings would not be preclusive but can be used as evidence in potential future litigation involving class members, and a robust notice program. The plan also includes research and diagnostic programs that were part of the original class agreement.

Monsanto will request permission from the Environmental Protection Agency to include a link to information concerning whether Roundup Products cause non-Hodgkin lymphoma on all Roundup labels.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Pharmacy, the retail division of CVS Health, announced the availability of three over-the-counter or OTC COVID-19 testing options in stores and online. With these new-to-market home tests, customers will get access to convenient testing that can be conducted at home. The tests include the Ellume COVID-19 Home Test, the Abbott BinaxNOW COVID-19 Antigen Self Test and the Pixel by Labcorp PCR Tes United Airlines is adding three new flights to Croatia, Greece and Iceland, which are starting to reopen to vaccinated visitors. The move would give travelers more options for summer travel by flying direct to these countries. Last month's searches on United.com for flights to Croatia, Greece and Iceland were up 61 percent. Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden.
Follow RTT